Outcomes | E-cadherin | P | |
---|---|---|---|
High (n, %) | Low (n, %) | ||
Muscle invasion | |||
NMIBC | 14 (100) | 0 (0) | 0.06c |
MIBC | 20 (76.92) | 6 (23.08) | |
Stage | |||
I | 13 (100) | 0 (0) | 0.02b |
II | 7 (87.5) | 1 (12.5) | |
III | 7 (100) | 0 (0) | |
IV | 7 (58.3) | 5 (41.67) | |
Grade | |||
Low | 14 (100) | 0 (0) | 0.06c |
High | 20 (76.92) | 6 (23.08) | |
Metastasis | |||
No | 33 (94.29) | 2 (5.71) | 0.001c |
Yes | 1 (20) | 4 (80) | |
Multifocality | |||
No | 10 (71.43) | 4 (28.57) | 0.1c |
Yes | 24 (92.31) | 2 (7.69) | |
Recurrence | |||
No | 21 (84) | 4 (16) | 0.6c |
Yes | 13 (86.67) | 2 (13.33) | |
Mortalitya | |||
No | 13 (86.67) | 2 (13.33) | 0.29c |
Yes | 5 (62.5) | 3 (37.5) |